miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
| Author | |
|---|---|
| Abstract |
:
High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related to HCC metastasis. Whether the expression of miR-182-5p in tumor tissue correlated with early recurrence in HCC patients underwent curative surgery was unknown. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of hematology & oncology
|
| Volume |
:
11
|
| Issue |
:
1
|
| Number of Pages |
:
12
|
| Date Published |
:
2018
|
| URL |
:
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-018-0555-y
|
| DOI |
:
10.1186/s13045-018-0555-y
|
| Short Title |
:
J Hematol Oncol
|
| Download citation |
